Insertable Cardiac Monitors (ICM) and Remote Monitoring May

Presentation at ACC.22 shows early treatment of high-risk NSTEMI patients guided by continuous arrhythmia monitoring with ICMs may reduce major adverse cardiac events (MACE).

Related Keywords

Australia , Denmark , Berlin , Germany , Washington , United States , Aalborg , Nordjylland , Erik Bloch Thomsen , Klaus Contzen , Steffen Behrens , Clinical Affairs , Aalborg University , American College Of Cardiology , Clinical Research , Aalborg University Hospital , Rigshospitalet Copenhagen , Late Breaking Clinical Trial , American College , Annual Scientific Session , Poul Erik Bloch Thomsen , Vivantes Humboldt Klinikum , Home Monitoring , Vice President Clinical Affairs ,